...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Shareholders

Koo, soo after your checking are the main numbers a good approx of ZCC? Ballpark?

It looks like they are. Thanks.

Toinv

Share
New Message
Please login to post a reply